1. Smith & Nephew named Mr. Baker CFO in November 2016. He officially began serving the position in March 2017.
2. Prior to joining smith & Nephew, Mr. Baker served as CFO of generic pharmaceuticals company Alvogen.
3. Mr. Baker spent 20 years at AstraZeneca. At the company, he served as vice president of finance and CFO of North America, vice president of global financial services and vice president of finance and international.
4. Mr. Baker has extensive knowledge in emerging markets.
5. He earned his master of arts degree in economics from Cambridge, England-based Cambridge University. Mr. Baker is also a chartered accountant and chartered tax adviser.
More articles on devices and implants:
Life Spine highlights advancements to its micro-invasive solutions — 4 highlights
Intralink-Spine expands clinical trials to Australia, New Zealand: 4 takeaways
Cervical discs dominate global artificial spinal disc market with 68% market share in 2017 — 7 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
